Clinical Trial

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-09-21; most recent amendment 2024-08-29.
Status change: Not Yet Recruiting → Recruiting 2024-08-29
Trial Details
NCT Number NCT06058546
Lead Sponsor Tasly Pharmaceutical Group Co., Ltd
Conditions Plaque Psoriasis
Enrollment 180 participants
Start Date 2023-11-23
Primary Completion 2025-10 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-03